Legend Biotech (LEGN) Change in Acquisitions & Divestments (2019 - 2026)

Legend Biotech (LEGN) has 8 years of Change in Acquisitions & Divestments data on file, last reported at $184.9 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 50.56% year-over-year to $184.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $571.3 million (down 61.23% YoY) and the FY2025 annual result came in at $46.7 million, down 94.44% from the prior year.
• Change in Acquisitions & Divestments climbed to $184.9 million in Q1 2026, from $46.7 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $3.9 billion in Q2 2025 to a low of -$3.6 billion in Q3 2025.
• A 5-year average of $333.8 million and a median of $190.6 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments jumped 2321.4% — and 2025, when it slumped 730.52%.
• Tracing LEGN's Change in Acquisitions & Divestments over 5 years: stood at $54.0 million in 2022, then plunged by 35.75% to $34.7 million in 2023, then jumped by 2321.4% to $840.3 million in 2024, then slumped by 94.44% to $46.7 million in 2025, then jumped by 295.93% to $184.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $184.9 million (Q1 2026), $46.7 million (Q4 2025), and -$3.6 billion (Q3 2025), per Business Quant data.